×

Seattle Genetics CEO: Blockbuster cancer drug?

3:15 PM ET Mon, 8 Dec 2014

Clay Siegall, Seattle Genetics CEO, discusses the company's center focus on treating Non-Hodgkin's lymphoma. Siegall tells CNBC's Meg Tirrell he is excited about the impact of the new drug on patients.